SPDR SP Financial Statements From 2010 to 2024
| XBI Etf | USD 96.24 1.94 2.06% |
Check SPDR SP financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among SPDR SP's main balance sheet or income statement drivers, such as , as well as many indicators such as . SPDR financial statements analysis is a perfect complement when working with SPDR SP Valuation or Volatility modules.
SPDR |
SPDR SP Biotech ETF Price To Earning Analysis
SPDR SP's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current SPDR SP Price To Earning | 19.71 X |
Most of SPDR SP's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SPDR SP Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, SPDR SP Biotech has a Price To Earning of 19.71 times. This is 189.85% higher than that of the SPDR State Street Global Advisors family and significantly higher than that of the Health category. The price to earning for all United States etfs is notably lower than that of the firm.
SPDR SP Biotech Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining SPDR SP's current stock value. Our valuation model uses many indicators to compare SPDR SP value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across SPDR SP competition to find correlations between indicators driving SPDR SP's intrinsic value. More Info.SPDR SP Biotech is rated first in price to earning as compared to similar ETFs. It is rated first in price to book as compared to similar ETFs fabricating about 0.13 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for SPDR SP Biotech is roughly 7.47 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the SPDR SP's earnings, one of the primary drivers of an investment's value.About SPDR SP Financial Statements
Investors use fundamental indicators, such as SPDR SP's revenue or net income, to determine how well the company is positioned to perform in the future. Although SPDR SP's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
In seeking to track the performance of the SP Biotechnology Select Industry Index , the fund employs a sampling strategy. SP Biotech is traded on NYSEARCA Exchange in the United States.
Currently Active Assets on Macroaxis
When determining whether SPDR SP Biotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of SPDR SP's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Spdr Sp Biotech Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Spdr Sp Biotech Etf:Check out the analysis of SPDR SP Correlation against competitors. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
The market value of SPDR SP Biotech is measured differently than its book value, which is the value of SPDR that is recorded on the company's balance sheet. Investors also form their own opinion of SPDR SP's value that differs from its market value or its book value, called intrinsic value, which is SPDR SP's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SPDR SP's market value can be influenced by many factors that don't directly affect SPDR SP's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SPDR SP's value and its price as these two are different measures arrived at by different means. Investors typically determine if SPDR SP is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SPDR SP's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.